Infusion Associates PLLC

Infusion Associates PLLC was paid $6.14M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is Q5103, Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg — 27% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,416	$532K
2019	2,214	$336K
2020	4,111	$640K
2021	7,666	$867K
2022	12,493	$988K
2023	13,753	$1.44M
2024incomplete	8,164	$1.34M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	27%	1,131	1,079	$1.68M
J3380	Injection, vedolizumab, intravenous, 1 mg	14%	189	179	$848K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	13%	406	341	$798K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	12%	529	497	$749K
J2357	Injection, omalizumab, 5 mg	9.9%	447	391	$608K
J1439	Injection, ferric carboxymaltose, 1 mg	7.9%	792	515	$483K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	7.0%	14,587	6,238	$431K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	3.4%	4,434	4,125	$209K
J1756	Injection, iron sucrose, 1 mg	1.3%	2,137	822	$78K
J2356	Injection, tezepelumab-ekko, 1 mg	1.1%	36	36	$66K
96415		<1%	3,657	3,420	$47K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,720	956	$41K

20 more codes

96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	2,226	$31K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,093	$17K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	2,864	$12K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,131	$11K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	717	$10K
36415	Collection of venous blood by venipuncture	<1%	4,343	$10K
96367		<1%	561	$8K
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,194	$3K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	108	$2K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	<1%	18	$1K
J3411	Injection, thiamine hcl, 100 mg	<1%	545	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,944	$1K
J3489	Injection, zoledronic acid, 1 mg	<1%	39	$889.79
J3480	Injection, potassium chloride, per 2 meq	<1%	356	$382.08
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	174	$338.57
J3490	Unclassified drugs	<1%	202	$318.77
J7120	Ringers lactate infusion, up to 1000 cc	<1%	86	$226.92
J3475	Injection, magnesium sulfate, per 500 mg	<1%	50	$189.51
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	89	$83.12
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	12	$45.82

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMAWBY, MICHAEL (PRESIDENT)